A detailed history of N Verses Capital, LLC transactions in Artivion, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 1,300 shares of AORT stock, worth $37,791. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,300
Previous 1,100 18.18%
Holding current value
$37,791
Previous $28.2 Million 22.65%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$24.33 - $28.46 $4,866 - $5,692
200 Added 18.18%
1,300 $34.6 Million
Q2 2024

Jul 31, 2024

BUY
$19.62 - $25.65 $21,582 - $28,215
1,100 New
1,100 $28.2 Million

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.17B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.